Why is Titan Biotech falling/rising?

As of 17-Oct, Titan Biotech Ltd's stock is currently priced at 1,264.20, reflecting a decrease of 25.75 points or 2.0%. The stock has been underperforming, having fallen for the last two consecutive days, resulting in a total decline of 6.89% during this period. It opened today with a loss of 2% and reached an intraday low of the same price. Despite this recent downturn, the stock has shown strong performance over longer periods, with a year-to-date increase of 72.53% and a remarkable 379.41% rise over the past three years. However, there has been a notable decline in investor participation, with delivery volume dropping by 12.74% compared to the five-day average, indicating reduced interest among investors.
Broader market context shows that Titan Biotech's short-term performance has been significantly better than the benchmark, with a weekly return of 6.63% compared to the Sensex's 1.76%. Despite the recent price drop, the stock has consistently traded above its moving averages across various timeframes, suggesting underlying strength. The broader market has also seen positive movements, but Titan Biotech's recent performance indicates a divergence from this trend, likely influenced by the falling investor participation and the stock's recent consecutive losses.